We report a highly specific fluorescence lifetime imaging microscopy (FLIM) method for monitoring epidermal growth factor receptor (EGFR) phosphorylation in cells based on fluorescence resonance energy transfer (FRET). EGFR phosphorylation was monitored using a green fluorescent protein (GFP)-tagged EGFR and Cy3-conjugated anti-phosphotyrosine antibodies. In this FRET-based imaging method, the information about phosphorylation is contained only in the (donor) GFP fluorescence lifetime and is independent of the antibodyderived (acceptor) fluorescence signal. A pixel-by-pixel reference lifetime of the donor GFP in the absence of FRET was acquired from the same cell after photobleaching of the acceptor. We show that this calibration, by acceptor photobleaching, works for the GFP-Cy3 donor-acceptor pair and allows the full quantitation of FRET efficiencies, and therefore the degree of exposed phosphotyrosines, at each pixel. The hallmark of EGFR stimulation is receptor dimerisation 
Results and discussion
GFP was fused to the carboxyl terminus of the EGFR (EGFR-GFP) via a six-glycine linker (see Supplementary material) to enable monitoring of intracellular binding events by FRET (Figure 1 ). The integrity of the expressed protein was confirmed by western blotting of transfected Cos-7 cells and immunodetection with anti-GFP antibodies. A single ~200 kDa polypeptide was detected, indicating that the expressed fusion protein is proteolytically stable in the cells (data not shown). Receptor function in response to EGF stimulation was verified by following its distribution by conventional immunofluorescence. Serumstarved cells showed a homogeneous plasma-membrane distribution of EGFR-GFP. Occasionally, EGFR-GFP accumulated in compartments of the protein synthesis pathway in cells expressing high levels of the fusion protein. Stimulation with 100 ng/ml EGF caused aggregation of the EGFR-GFP associated with the plasma membrane, followed by receptor internalisation at longer stimulation times. Proper EGF binding was shown by the colocalisation of Cy3-labeled EGF and EGFR-GFP at the plasma membrane and, after endocytosis, on endosomes (data not shown). The presence of a GFP moiety on the EGFR has previously been shown not to interfere with its proper functioning in cells [12, 13] .
Total EGF-dependent phosphorylation of EGFR-GFP was indicated by immunoprecipitation of the EGFR-GFP with an anti-GFP antibody and subsequent detection with an anti-phosphotyrosine antibody. Negligible phosphorylation was detected before EGF stimulation in quiescent Cos-7 cells. Upon stimulation with 100 ng/ml EGF, the EGFR-GFP was rapidly phosphorylated and this phosphorylation level was sustained throughout the 30 minute stimulation period (Figure 2a ). Quiescent Cos-7 cells were stimulated with EGF, fixed and incubated with Cy3-labeled anti-phosphotyrosine antibodies (see Supplementary material and [14] ).
Frequency domain FLIM [15] [16] [17] was used to map the fluorescence lifetimes of the GFP moiety of the EGFR-GFP in cells at different time points during EGF stimulation. The fluorophores GFP and Cy3 form a favourable Förster donor-acceptor pair with an R 0 value (defined as the distance at which 50% of the excited donor molecules transfer energy by FRET) of 6 nm [18] . This allows for efficient detection of FRET at inter-chromophore distances of up to approximately 9 nm. The fluorescence lifetime of EGFR-GFP decreases because of FRET to Cy3. As FRET occurs over distances that are in the same order of magnitude as protein dimensions, detectable FRET efficiencies can be interpreted as a direct interaction between phosphorylated EGFR-GFP and Cy3-labeled anti-phosphotyrosine antibodies. Complete photobleaching of the Cy3 acceptor by continuous illumination provides a pixel-by-pixel reference GFP donor fluorescence lifetime for the calculation of FRET efficiencies ( Figure 1 ). An alternative readout for EGFR-GFP phosphorylation is provided by determining FRET from the recovery of GFP fluorophore (donor) emission intensity after photobleaching of the acceptor [19] . The latter is performed in a confocal microscopy set-up in which FRET is determined in a defined region of the cell where the Cy3 acceptor is photobleached by repeated scanning.
The EGFR-GFP showed a plasma membrane distribution when expressed in quiescent Cos-7 cells, and nascent protein was located in compartments of the secretory pathway (Figure 2b ). Upon EGF stimulation, EGFR-GFP translocated from the plasma membrane to punctate structures that represent vesicles in various stages of endocytosis (Figure 2b,3) . In quiescent cells, the corresponding Cy3-labeled anti-phosphotyrosine antibody distribution (Figure 2c ) was limited to punctate structures and the cell perimeter, a distribution that corresponds to phosphorylation sites that are independent of growth factor stimulation, for example, those located at focal adhesions. Despite colocalisation of the EGFR-GFP at the plasma membrane and the phosphotyrosines at focal adhesions, the fluorescence lifetime image showed no FRET at these sites (Figure 2d , time 0), confirming that the FRETbased imaging approach only reports on phosphotyrosine residues on the EGFR-GFP. Upon EGF stimulation, the anti-phosphotyrosine antibody staining largely colocalised with the EGFR-GFP distribution, with particularly high phosphorylation levels in membrane ridges and additional punctate structures (Figure 2c ). Although, as expected, short lifetimes were generally associated with high levels of anti-phosphotyrosine staining, there were significant differences. Structures with high phosphotyrosine content were seen that exhibited low FRET efficiencies at the plasma membrane and in punctate structures after 5 and 10 minutes of EGF stimulation ( Figure 2d ). These sites must therefore contain phosphorylated proteins other than the EGFR-GFP, for example, recruited EGFR tyrosinekinase substrates. Furthermore, EGFR-GFP in the secretory pathway provided an internal control for the FRET measurements because it should have been unresponsive to EGF stimulation. Indeed, this can be seen at all timepoints measured: no energy transfer was detected for the nascent receptor in the perinuclear region. The presence of FRET in other structures was confirmed by photobleaching of the Cy3 acceptor, which resulted in a homogeneous distribution of GFP fluorescence lifetimes similar to those seen in the unstimulated situation (Figure 2e,g ). These results show that acceptor photobleaching can indeed be used to calibrate FRET determinations via donor lifetime measurements. The reference GFP lifetime maps obtained after Cy3 acceptor photobleaching enabled the pixel-by-pixel calculation of FRET efficiency maps ( Figure 2f ). An alternative procedure was used to obtain FRET efficiencies on a confocal microscope by unquenching GFP donor emission after Cy3 photodestruction by repeated scanning. In Cos-7 cells expressing EGFR-GFP, the FRET efficiencies obtained this way after 5 minutes of EGF stimulation were comparable (0.2-0.25) to those obtained by FLIM ( Figure 3 ). As can be seen by comparing Figures 2 and 3 , the confocal acceptor-photobleaching method yields noisier FRET maps and furthermore proper image registration is essential. The FLIM approach is inherently more sensitive and does not suffer from photobleaching of the donor because the fluorescence lifetime is an intrinsic property of the fluorophore and therefore independent of emission intensity.
The GFP fluorescence lifetimes at later time points during EGF stimulation (from 20 minutes) revert to the distribution seen in the absence of FRET (Figure 2d,g ). The phosphotyrosine staining at these time points decreased compared to earlier time points of stimulation, but still showed punctate structures. As phosphorylation of the EGFR-GFP persisted, as judged by immunoprecipitation (Figure 2a ), this loss of FRET can only be accounted for by the shielding of epitopes by proteins recruited to the activated receptors in endosomes. These results were also consistently reproduced in NR6 fibroblasts that are devoid of endogenous EGFR and in MCF-7 breast carcinoma cells (data not shown). In all cells tested, the observed effect was independent of EGFR-GFP expression level. This pattern of EGF-dependent phosphorylation can also be seen in the two-dimensional histograms (Figure 2g) , in which the phase lifetime (τ φ ) and modulation lifetime (τ M ) values for each pixel are plotted. Before stimulation, the distribution of lifetimes after acceptor photobleaching (red) showed a stable homogeneous distribution that overlapped the distribution of lifetimes measured in the presence of acceptor (green; overlap is yellow). Upon EGF stimulation for 5 minutes, FRET was seen as a shortening in both lifetimes, giving rise to a new population with shorter lifetimes (green). A significant 'tail' of pixels with even shorter lifetimes was present after 10 minutes of EGF stimulation, indicating the presence of highly phosphorylated EGFR-GFP species. At later time points, the lifetime distributions in the presence and absence of acceptor converged again, indicating a loss of FRET. A number of studies have indeed suggested recruitment of Grb2, Shc, the Grb2-Shc-mSOS complex and Ras-GAP to the phosphorylated EGFR in endosomes [20] . Furthermore, the molecules involved in the MAP-kinase signal transduction pathway have been identified in endosomes [21] . Internalisation is generally viewed as an attenuation mechanism. The cytosolic orientation of the EGFR phosphotyrosine residues, however, implies that the complex of associated signaling molecules can be brought into close proximity of other cytosolic targets by receptor endocytosis and thereby provides an attractive alternative scenario for sustained signal transduction [22] .
As can be seen from the differences between the phosphotyrosine and FRET distributions, conventional colocalisation studies do not accurately report on phosphorylated species when other tyrosine-phosphorylated proteins are also present in the same location. Although the use of antibodies specific for the phosphorylated EGFR could alleviate this problem, such antibodies are restricted to a single phosphotyrosine epitope and for many phosphorylated proteins, antibodies are not yet available. Most importantly, antibody staining does not provide a quantitative measure of the extent of phosphorylation, in contrast to the FRET determination. Because FRET is measured on the donor fluorophore independently of the acceptor fluorescence, non-specific interaction of the anti-phosphoaminoacid antibody is of no consequence to the measurement. This means that serine phosphorylation could also be measured by this approach as anti-phosphoserine antibodies are usually not as specific as anti-phosphotyrosine antibodies. For the same reason, the relative intensities of the GFP fluorescence and the immunolabeling have no effect on the measurements, enabling detection of phosphorylation in cells with low expression levels of the GFP protein, even in the presence of extensive immunolabeling. This allows selectivity to be sacrificed in favour of achieving higher epitope occupancy with higher antibody Brief Communication 1129 concentrations. Acceptor photobleaching to abolish FRET is a simple operation that allows the unequivocal assignment of decreased lifetimes to FRET by providing a pixelby-pixel calibration in the same cell, and effectively reducing inter-sample variation. This type of imaging assay is generally applicable to other systems, in which a GFPtagged protein and antibodies against a binding candidate are available.
Supplementary material
Supplementary material including additional methodological detail is available at http://current-biology.com/supmat/supmatin.htm. 
Supplementary materials and methods

EGFR-GFP construction
A unique PvuI restriction site and six glycine residues were introduced directly upstream of EGFP by ligation of a linker (formed by annealing GATCGGTGGAGGTGGAGGAGGC and CCTCCTCCACCTCCAC-CGATCG oligonucleotides) into the unique XcmI site of pEGFP-N3. The 2927 bp NheI-BglII fragment of human EGFR (Genbank accession number X00588) was subcloned into the respective sites in the modified pEGFP-N3. The 3′ part of the EGFR cDNA was obtained by PCR with primers designed to include the BglII site (GAGTTGATGAC-CTTTGGATCCAAGCCATA) and to introduce a unique PvuI site (TGGCTAGCGACGAGGTTATTTAAGTGACGAAACAC). The fulllength construct was obtained by ligation of the 929 bp BglII-PvuI fragment of the PCR product into the respective sites of the host vector and was confirmed by sequence analysis.
Immunoprecipitation
Cos-7 cells were transfected with EGFR-GFP by lipofection (Fugene, Boehringer Mannheim) for 24-36 h and were starved for 12 h. The Cos-7 cells were stimulated for the indicated times with 100 ng/ml mouse submaxillary gland EGF (Sigma) and were lysed in modified RIPA buffer (1% Triton X-100, 0.5% NaDoC, 0.1% SDS, 0.2% NaN 3 , 0.04% NaF, 2 mM NaVO 3 and 1× complete protease inhibitor mix (Boehringer Mannheim)) for 20 min at 4°C. EGFR-GFP was immunoprecipitated with 15 µg of anti-GFP monoclonal antibody (3E1) and protein A sepharose (Biorad). The immunoprecipitate was electrophoresed, transferred to nitrocellulose by western blotting and phosphotyrosine-containing proteins were detected using 2.5 µg/ml anti-phosphotyrosine antibody (PY72) by enhanced chemiluminescence (ECL; NEN/Dupont).
Fluorescence lifetime imaging microscopy
Cos-7 cells expressing EGFR-GFP were fixed in 4% formaldehyde + 1 mM NaVO 3 and then permeabilised with 0.1% Triton X-100 in phosphate-buffered saline for 10 min. The cells were incubated with 15 µg/ml Cy3-labeled (Cy3:protein ratio = 8) PY72 antibody and mounted in 0.1 M Tris-HCl, 25% (wt/vol) glycerol, and 10% (wt/vol) Mowiol 4-88 (Hoechst).
FLIM was performed on a Zeiss Axiovert 135 TV microscope equipped with a 100×/NA 1.4 plan-apochromat objective. EGFR-GFP was excited at 488 nm using a Coherent Innova Argon/Krypton laser modulated at 80.244 MHz. GFP emission was detected using a 505 LP dichroic mirror (Chroma) and a 514/10 BP emission filter (Delta Lys & Optik). A series of phase-dependent images was acquired as described in [S1] and used to determine GFP lifetimes from phase shift (τ φ ) and demodulation (τ M ) on a pixel-to-pixel basis.
Energy transfer efficiency maps were calculated from fluorescence lifetime maps according to: E = 1-(<τ> DA /<τ> D ) where <τ> DA is the average of the lifetimes determined from the phase shift (τ φ ) and demodulation (τ m ) of the donor emission in presence of the acceptor and <τ> D after photobleaching of the acceptor.
Confocal acceptor-photobleaching FRET imaging
Acceptor-photobleaching imaging was performed on a Zeiss LSM 510 confocal microscope with 488 nm (Argon laser) GFP and 633 nm (Helium/Neon laser) Cy3 excitation. GFP emission was detected using a BP 505-530 nm filter and Cy3 using a BP 560-605 nm filter.
In this approach the quenching of donor fluorescence intensity by FRET was utilised by acquisition of a donor (GFP) image before and after photobleaching of the acceptor, essentially as described in 
